?(Fig.2J).2J). HNSCC cell lines. Together we demonstrate that CIP2A is usually a novel Oct4 target gene in stem cells and in human malignancy cell lines. Clinically these results suggest that diagnostic evaluation of HNSCC tumors for Oct4 or Oct4/CIP2A positivity might help to predict HNSCC tumor radioresistancy. These results also identify both Oct4 and CIP2A as potential targets for radiosensitation. tumour formation [25, 26]. Clinically, high CIP2A expression correlates with worsened patient survival in more than dozen different cancer types [25]. Linked to its function as an inhibitor of PP2A, a grasp regulator of cellular signaling, CIP2A expression promotes various malignancy driver pathways and thus many aspects of aggressive cell growth such as proliferation, apoptosis resistance or senescence evasion [27, 28]. Importantly, CIP2A is usually expressed at very low level in other normal tissues than testis, and its systematic inhibition do not cause detrimental consequences to normal mouse development and viability [28, 29]. However, CIP2A-deficient mice do show decreased Her2-driven mammary tumor development [28]. Therefore inhibition of CIP2A may have clinical relevance in development of future malignancy therapies. In our recent work we exhibited that CIP2A is usually highly expressed in testicular stem cells and has a role in regulation of spermatogonial progenitor proliferation. Moreover, spermatogonial cells isolated from CIP2A mutant mice showed reduced expression of Plzf (promyelocytic leukaemia zinc finger) and other stem cell renewal-associated genes, suggesting a role for CIP2A in testicular stem and progenitor cells. However, the functional relationship between CIP2A and stem cell renewal genes, such as Oct4 is not clear. Also, the potential role for CIP2A in mediating radioresistancy of HNSCCs has not been addressed thus far. In this work we identify a novel function for stem cell regulator Oct4 in regulating oncoprotein CIP2A expression. Functionally, we demonstrate that Oct4/CIP2A double positivity is usually associated with radioresistancy in both normal spermatogonial cells, as well as in HNSCC. Clinically these results suggest that diagnostic evaluation of HNSCC tumors for Oct4 or Oct4/CIP2A positivity might help to predict HNSCC tumor radioresistancy. RESULTS Oct4 and CIP2A are expressed in radioresistant cell populace in the mouse testis Previous studies have exhibited that testicular stem cells (spermatogonia) contain great pluripotent capacity and mimic in many ways embryonic stem cells [30, 31]. CIP2A is usually expressed in testicular stem cell/progenitor populace (Fig. ?(Fig.1A)1A) and our recent results suggest that CIP2A promotes self-renewal of normal testicular spermatogonia expressing and [29]. To study whether CIP2A is usually expressed in the radioresistant stem cell populace, we used a novel approach to identify the spermatogonial genes involved in stemness based on their expression profiles in response to irradiation [32]. To avoid systemic side-effects, mouse testes were X-irradiated with 4 Gy under CT-scan guidance (Fig. ?(Fig.1B;1B; [32]). Changes in gene expression profiles in response to irradiation were studied as a function of time. Spermatogonial genes that did not show inhibition of expression were considered to UNC0379 be expressed in radioresistant spermatogonial stem cells [32]. Expression of stra8 and or CIP2A did not significantly change over the 144-hour observation period (Fig. ?(Fig.1C),1C), whereas the spermatogonial markers and showed a strong increase at 96 and 144 hours after irradiation, coinciding with increased proliferation and repopulation of the spermatogonia. Regarding CIP2A and Stra8 these results were confirmed by immunohistochemical staining of testis samples 144 hours UNC0379 after irradiation (Supplementary Physique 1). These results indicate that expression of both CIP2A and Oct4 is UNC0379 usually linked to cellular radioresistance = 3C7, SEM; a, 0.001; b, 0.05 when compared to 0 h (= control) value; c, 0.05 when compared to 6 hours after X-irradiation. Statistical significancies were tested using one-way ANOVA and Dunnett post hoc assessments. Letters a, b and c next to the error bars are in different colors based on the color of the line marking the gene. CIP2A is an Oct4 target gene in testicular cancer cells and in embryonic stem cells Results Rabbit polyclonal to AGMAT above, together with our previous results [29] indicate that CIP2A expression is usually linked to expression of Oct4 in normal mammalian progenitor cells. However, these studies have not yet resolved whether these genes regulate each other’s expression. Testicular cancer (TC) is a good model to study regulatory mechanisms related to cell stemness [36]..